Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum
April 3rd, 2019
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Loftex Sets New Standard in Sustainability Utilizing CertainT
April 2nd, 2019
Applied DNA Announces Exclusive Cannabis Licensing and Cooperation Agreement with TheraCann International
March 29th, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
Applied DNA Reports FY’19 Q1 Results
February 7th, 2019
Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)
February 6th, 2019
Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board
January 29th, 2019
Tex-Ray to Introduce CertainT® to Global Textile Brands
January 28th, 2019
Sun Chemical to Bring CertainT® to Textile Manufacturers in Asia
January 24th, 2019
